PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Gene knockout shows potential for diabetes-related heart failure

2010-12-10
(Press-News.org) Silencing the TLR4 gene can stop the process which may lead to cardiovascular disease in diabetic patients. Researchers writing in BioMed Central's open access Journal of Translational Medicine carried out a series of in vitro tests which demonstrated that TLR4 plays a critical role in hyperglycaemic cardiac apoptosis, and that silencing the gene using specific small interfering RNA (siRNA) can prevent it.

Wei-Ping Min, from the University of Western Ontario, Canada, worked with a team of researchers to perform the tests in cells taken from diabetic mice. He said, "We found that TLR4 was up-regulated in the myocardia of diabetic mice. Treatment with TLR4 siRNA attenuated the apoptosis seen in these cells, thus highlighting the potential clinical use of siRNA-based therapy".

Min and his colleagues induced hyperglycemia in adult mice by injecting them with streptozotocin, a toxin that poisons insulin-producing beta cells. They found that after 7 days of hyperglycemia, the level of TLR4 mRNA in myocardial tissue was significantly elevated, and signs of apoptosis were evident. Silencing TLR4 resulted in suppression of apoptotic cascades. According to Min, "This is the first demonstration of the prevention of cardiac apoptosis in diabetic mice through silencing of the TLR4 gene".

###

Notes to Editors

1. Prevention of hyperglycemia-induced myocardial apoptosis by gene silencing of Toll-like receptor-4
Yuwei Zhang, Tianqing Peng, Huaqing Zhu, Xiufen Zheng, Xusheng Zhang, Nan Jiang, Xiaoshu Cheng, Xiaoyan Lai, Aminah Shunnar, Manpreet Singh, Neil Riordan, Vladimir Bogin, Nanwei Tong and Wei-Ping Min
Journal of Translational Medicine (in press)

During embargo, article available here: http://www.translational-medicine.com/imedia/1346785410443037_article.pdf?random=654892

After the embargo, article available at the journal website: http://www.translational-medicine.com/

Please name the journal in any story you write. If you are writing for the web, please link to the article. All articles are available free of charge, according to BioMed Central's open access policy.

Article citation and URL available on request at press@biomedcentral.com on the day of publication.

2. Journal of Translational Medicine is an open access journal publishing articles focusing on information derived from human experimentation so as to optimise the communication between basic and clinical science.

3. BioMed Central (http://www.biomedcentral.com/) is an STM (Science, Technology and Medicine) publisher which has pioneered the open access publishing model. All peer-reviewed research articles published by BioMed Central are made immediately and freely accessible online, and are licensed to allow redistribution and reuse. BioMed Central is part of Springer Science+Business Media, a leading global publisher in the STM sector.

END



ELSE PRESS RELEASES FROM THIS DATE:

Plant disease 'stealth bomber' tactics subverted to tackle hundreds of plant pathogens

2010-12-10
Research, led by the University of Warwick, The Sainsbury Laboratory, and Virginia Polytechnic Institute and State University (Virginia Tech), has sequenced the genome of a plant disease causing organism revealing that it acts like a "stealth bomber of plant pathogens". The research has uncovered the tactics used to sneak past the plant's immune defences. That same discovery also provides tools for researchers to identify the components of the plant immune system and devise new ways to prevent disease. The research at the University of Warwick, the Sainsbury Laboratory ...

Identifying lung cancer gene markers shows promise in identifying patients needing chemo

2010-12-10
Cancer researchers have identified six gene markers present in early stage non-small cell lung cancer (NSCLC) that show promise in helping oncologists better identify which tumors will relapse after curative surgery, according to a study presented at the 2010 Chicago Multidisciplinary Symposium in Thoracic Oncology. This symposium is sponsored by the American Society for Radiation Oncology (ASTRO), the American Society of Clinical Oncology (ASCO), the International Association for the Study of Lung Cancer (ISLAC) and the University of Chicago. Lung cancer is the leading ...

Researchers track the impacts of depression during pregnancy

2010-12-10
ANN ARBOR, Mich. — The cocktail of hormones cascading through depressed mothers' bodies may play an important role in the development of their unborn children's brains. A higher level of depression in mothers during pregnancy was associated with higher levels of stress hormones in their children at birth, as well as with other neurological and behavioral differences, a University of Michigan-led study found. "The two possibilities are that they are either more sensitive to stress and respond more vigorously to it, or that they are less able to shut down their stress ...

Exposure to North Dakota road material may increase risk of lung cancer

2010-12-10
New data shows that people exposed to the mineral erionite found in the gravel of road materials in North Dakota may be at significantly increased risk of developing mesothelioma, a type of lung cancer most often associated with asbestos exposure, according to research presented at the 2010 Chicago Multidisciplinary Symposium in Thoracic Oncology. This symposium is sponsored by the American Society for Radiation Oncology (ASTRO), the American Society of Clinical Oncology (ASCO), the International Association for the Study of Lung Cancer (ISLAC) and The University of Chicago. Erionite ...

Personalized molecular therapy shows promising results for people with advanced lung cancer

2010-12-10
A new study shows that a combination of epigenetic therapy and molecular targeted therapy has promising results at combating advanced lung cancer according to research presented at the 2010 Chicago Multidisciplinary Symposium in Thoracic Oncology. This symposium is co-sponsored by the American Society for Radiation Oncology (ASTRO), the American Society of Clinical Oncology (ASCO), the International Association for the Study of Lung Cancer (ISLAC) and The University of Chicago. Epigenetics therapy is an approach designed to control the expression of good and bad genes ...

Adding ipilimumab to standard chemotherapy treatment for late-stage lung cancer may improve survival

2010-12-10
– Ipilimumab used in combination with paclitaxel/carboplatin for stage IIIb/IV non-small cell lung cancer showed superior results in progression free survival when compared to paclitaxel/carboplatin alone, according to research presented at the 2010 Chicago Multidisciplinary Symposium in Thoracic Oncology. This symposium is sponsored by the American Society for Radiation Oncology (ASTRO), the American Society of Clinical Oncology (ASCO), the International Association for the Study of Lung Cancer (ISLAC) and the University of Chicago. Paclitaxel/carboplatin are commonly ...

Non-invasive SRT as good as surgery for elderly patients with early lung cancer

2010-12-10
A new study shows that a new type of targeted radiation therapy called stereotactic radiation therapy is just as good as surgery for patients aged 75 and older with early-stage lung cancer, according to research presented at the 2010 Chicago Multidisciplinary Symposium in Thoracic Oncology. This symposium is sponsored by the American Society for Radiation Oncology (ASTRO), the American Society of Clinical Oncology (ASCO), the International Association for the Study of Lung Cancer (ISLAC) and the University of Chicago. In this study, researchers compared two treatments ...

Weekend and public holiday admissions increased the risk of hospital deaths by up to 41 percent

2010-12-10
Patients treated by Welsh (UK) hospitals for upper gastrointestinal (GI) bleeding were 41% more likely die if they were admitted on a public holiday and 13% more likely if it was at the weekend, according to research in the January issue of Alimentary Pharmacology and Therapeutics. Researchers who analysed the records of 22,299 people admitted a total of 24,421 times between 1999 and 2007 also found that admissions, but not death rates, were significantly influenced by social deprivation. "The higher death rates for weekend and public holiday admissions could not ...

Greedy algorithms best for multiple targets

2010-12-10
What algorithms should an air defense system work with? Particle swarm algorithms if there are ten targets to be hit. If there are more than ten targets, greedy algorithms work best. These findings are presented by researcher Fredrik Johansson at the Informatics Research Centre, University of Skövde, in Sweden. So-called TEWA systems (Threat Evaluation & Weapon Allocation) are used to protect strategic targets from enemy attacks, such as an airfield that needs to be protected from incoming missiles. The systems discover threats, evaluates the threats, and aims the defender's ...

Bioengineers develop bacterial strain to increase ethanol biofuel production

2010-12-10
Georgia, US - A team of Bioengineers in the United States have modified a strain of bacteria to increase its ability to produce ethanol. The research, published in Biotechnology and Bioengineering, reveals how adaptation and metabolic engineering can be combined for strain improvement, a positive development for the biofuel industry. The team focused their research on Zymomonas mobilis, a bacterium noted for its bio-ethanol producing potential. However, the team believed that ethanol production could be increased through improvement of xylose fermentation. "Zymomonas ...

LAST 30 PRESS RELEASES:

Advancements in muon detection: Taishan Antineutrino Observatory's innovative top veto tracker

Chips off the old block

Microvascular decompression combined with nerve combing for atypical trigeminal neuralgia

Cutting the complexity from digital carpentry

Lung immune cell type “quietly” controls inflammation in COVID-19

Fiscal impact of expanded Medicare coverage for GLP-1 receptor agonists to treat obesity

State and sociodemographic trends in US cigarette smoking with future projections

Young adults drive historic decline in smoking

NFCR congratulates Dr. Robert C. Bast, Jr. on receiving the AACR-Daniel D. Von Hoff Award for Outstanding Contributions to Education and Training in Cancer Research

Chimpanzee stem cells offer new insights into early embryonic development

This injected protein-like polymer helps tissues heal after a heart attack

FlexTech inaugural issue launches, pioneering interdisciplinary innovation in flexible technology

In Down syndrome mice, 40Hz light and sound improve cognition, neurogenesis, connectivity

Methyl eugenol: potential to inhibit oxidative stress, address related diseases, and its toxicological effects

A vascularized multilayer chip reveals shear stress-induced angiogenesis in diverse fluid conditions

AI helps unravel a cause of Alzheimer's disease and identify a therapeutic candidate

Coalition of Autism Scientists critiques US Department of Health and Human Services Autism Research Initiative

Structure dictates effectiveness, safety in nanomedicine

Mission accomplished for the “T2T” Hong Kong Bauhinia Genome Project

Study identifies how malaria can lead to childhood cancer

An earth-abundant mineral for sustainable spintronics

What makes successful learners? How Minecraft can helps us understand social learning

Researchers create ‘super stem cells’, seeing potential for improved fertility treatment

Empathic comforting varies more within bonobo and chimpanzee species than between them

AACR 2025: Colon cancer risk reduction, predicting melanoma spread and new drug therapies among Ohio State findings

Landmark 20-year screening program drives down colorectal cancer cases, deaths

Can a baby’s DNA predict future disease? This study says it might

Gene mutations linked to worse outcomes in stomach cancer

Blood proteins can predict liver disease up to 16 years before symptoms

Study: New DNA-reading technology holds promise for rare disease research

[Press-News.org] Gene knockout shows potential for diabetes-related heart failure